Benzinga – InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Kelsey Ramsden, Co-Founder & CEO of MINDCURE

MINDCURE CEO Kelsey Ramsden appeared on an episode of Bell2Bell, a podcast dedicated to covering fast-moving industries. One topic of discussion was MINDCURE’s business model which consists of AI-driven digital therapeutics and psychedelic drug development. Public opinion surrounding psychedelics was also discussed, to which Kelsey aptly pointed out that people need this kind of help, and that science can overcome stigma.

Access the article here.